Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
6 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

  • Read FDA Master Protocol Guidance for Smarter Clinical Trials
    • Clinical Trial Regulation
    • Clinical Trial Strategy
    • Clinical Trial Design
    • Adaptive Clinical Trials
    • Decentralised Clinical Trials
    • AI in Clinical Trials
    • Clinical Data
    • Pharma Intelligence
    • Pharma Policy
    • Pharma Regulation
    • Patient Centricity and Outcomes
    • Patient Enrolment
    • Oncology
    • Precision Medicine
    • Translational Science and Biomarkers
    • Biologics
    • Cell and Gene Therapy
    • Next-gen Modalities
    • Tech and Innovation
    • Rare Diseases
    • Immunology and Immunotherapy
    • Infectious Diseases and Vaccines
    • Neurological Disease
    • Clinical Outcomes
    • Electronic Data Capture
    • Data Integrity
    • Biostatistics

    FDA Master Protocol Guidance for Smarter Clinical Trials

  • Read Can Deep Learning Survive the Precision Medicine Paradox?
    • Precision Medicine
    • Drug Discovery
    • Oncology
    • AI & Machine Learning
    • AI Drug Discovery
    • Biostatistics
    • Translational Science and Biomarkers
    • Rare Diseases
    • Multiomics
    • Preclinical Development
    • Personalised Healthcare
    • AI Pharma
    • LLMs in Pharma
    • Artificial Intelligence in Healthcare
    • Orphan Drugs
    • Tech and Innovation
    • Genetics & Molecular Biology
    • Biomedical R&D
    • biomarkers
    • Translational & Surgical Biology
    • Translational & Pre-clinical Research
    • The Discovery Loop
    • Machine Learning in Pharma
    • AI Drug Development
    • patient stratification
    • Computational Biology
    • Pharmaceutical R&D
    • Research Informatics

    Can Deep Learning Survive the Precision Medicine Paradox?

  • Read Genomic Governance Ensures Equity at the Core of Drug Discovery
    • Multiomics
    • AI Drug Discovery
    • Drug Discovery
    • Rare Diseases
    • AI & Machine Learning
    • Translational Science and Biomarkers
    • Pharma Policy
    • Clinical Trial Strategy
    • Biostatistics
    • Decentralised Manufacturing
    • AI governance
    • Medical Governance
    • Precision Medicine
    • Personalised Healthcare
    • Preclinical Development
    • Biomedical R&D
    • HTS and Automation
    • Genetics & Molecular Biology
    • Translational & Pre-clinical Research
    • The Discovery Loop
    • Computational Biology
    • biomarkers
    • pharma R&D
    • Pharmaceutical R&D
    • Research Informatics

    Genomic Governance Ensures Equity at the Core of Drug Discovery